CMS campaign to curb dementia antipsychotic prescribing leaves assisted living largely unaffected

Summary

The documented conduct chain in Marjorie Tingley’s case — family resistance to escalating antipsychotic medication, hospital transfers that escalated in response, a 30-day eviction notice, and death within weeks of transfer — illustrates a regulatory pattern that a JAMA-cited study and an inspector general report have documented as persisting across long-term care despite a 14-year Centers for Medicare & Medicaid Services campaign to reduce antipsychotic prescribing in dementia care.
The CMS Partnership to Improve Dementia Care produced measurable reductions in nursing-home antipsychotic prescribing but documented no effect on state-regulated assisted living facilities, the category where Vista Grande Villa operated and where, according to the underlying reporting, nearly half of roughly 1 million assisted living residents have Alzheimer’s or other dementia.
Hospital and ambulance records described Marjorie Tingley as cooperative and polite throughout her emergency-room transfers, contradicting the facility behavior logs that characterized her as a danger to staff and residents, while Vista Grande’s legal filing attributed her ER calm to medication and “familial love and attention” from her sons.
A Michigan Circuit Court judge has dismissed the negligence claim against Vista Grande on legal grounds, and the corporation has since become a wholly-owned subsidiary of Otterbein SeniorLife and was renamed Otterbein Jackson SeniorLife Community.
Eli Lilly’s 2009 guilty plea to allegations of improperly promoting Zyprexa for dementia in long-term care, and a 1975 Senate report describing “an ugly pattern of prescription drug misuse” in nursing homes, document that the prescribing pattern has been a federal and Congressional concern for half a century.
Possible developments include regulatory tightening through a CMS rule conditioning Medicare participation on antipsychotic stewardship or congressional extension of federal oversight to assisted living, discontinuity via whistleblower or class-action enforcement analogous to Lilly’s 2009 resolution, and reversal through reimbursement structures that compensate caregiver time rather than per-medication encounters.

A Jackson, Michigan, memory care facility’s escalating dispute with the family of an 85-year-old Alzheimer’s patient over antipsychotic medication ended in eight emergency-room transfers, a 30-day eviction notice, and death within weeks of transfer to another facility, according to a lawsuit and the underlying federal reporting. The case documents a regulatory pattern in which the Centers for Medicare & Medicaid Services’ 14-year campaign to reduce antipsychotic prescribing has produced measurable reductions in federally regulated nursing homes but documented no effect in state-regulated assisted living facilities — the category where Vista Grande Villa operated and where, according to the underlying reporting, nearly half of roughly 1 million assisted living residents have Alzheimer’s or other dementia.

The federal-state oversight gap in dementia antipsychotic prescribing

Federal oversight of antipsychotic prescribing in long-term care operates on a bifurcated architecture. Nursing homes are federally regulated facilities subject to survey, citation, and payment mechanisms tied to that oversight, and antipsychotics — excluding patients with schizophrenia — were given to 1 in 7 nursing home residents in 2025, according to the underlying reporting. The Centers for Medicare & Medicaid Services launched its Partnership to Improve Dementia Care in 2012 to target overprescribing of antipsychotics and other brain-altering medications in long-term care and has shown some success with reducing the use of antipsychotics in nursing homes.

The more than 6,000 assisted living facilities that specialize in dementia care, by contrast, operate under state, not federal, regulation. These facilities typically operate in locked buildings or units populated by people with cognitive damage and usually charge more than standard assisted living. Researchers examining prescribing trends through 2017 in those facilities concluded the federal campaign “did not appear to affect antipsychotic prescribing” in assisted living residents with dementia. A 2023 study published in JAMDA, the journal of the society representing post-acute and long-term care medicine, found that on average assisted living residents with dementia were prescribed an antipsychotic for nearly 13 percent of the time they lived there.

A JAMA study cited in the underlying reporting estimated that 1 in 4 Medicare beneficiaries with dementia are potentially inappropriately prescribed antipsychotics and other brain-altering medications that can cause delirium, falls, and hospitalizations. More than 5 million Medicare beneficiaries have a diagnosis of dementia, according to the underlying reporting. An inspector general report released in March identified “alarming instances of inappropriate use of antipsychotic drugs.”

Diseases that cause dementia damage the parts of the brain that regulate impulse control and perception, according to the underlying reporting; impaired people may become aggressive because of fear — particularly when they no longer recognize caregivers — or because they have no other way to communicate pain, hunger, or other needs.

The documented conduct chain at Vista Grande Villa

Marjorie Tingley, an 85-year-old Alzheimer’s patient and Detroit native, was a former volunteer reading teacher in the Jackson, Michigan, public school system and a certified financial planner; her husband, Eugene, died in 2010. Around 2018 her sons noticed she was becoming forgetful, and her memory deteriorated further after a head injury in a 2019 car collision. By 2021, the family placed her in the assisted living unit at the then-nonprofit Vista Grande Villa in Jackson, Michigan, which charged $9,150 per month for memory care, according to her lease. In 2023 Vista Grande told the family that her dementia had progressed and that she needed to move into the memory care unit or leave.

In early December 2024, Vista Grande contacted the family about behavioral incidents; facility records indicated that Tingley pushed an aide trying to help her use the bathroom, the aide almost fell; she yelled and kicked at staff trying to put on her shoes and socks; she wandered into another resident’s room and took a walker. Vista Grande behavior logs recorded her hitting, kicking, or elbowing aides on at least 10 days in November 2024.

The family — David and Mark Tingley, who shared power of attorney — asked that she first be tested for a urinary tract infection, which they said had caused her agitation in the past. The facility collected a sample but did not ensure it was tested by a lab for more than a week, requiring a retest, according to facility and medical records.

In mid-December, Vista Grande sent Tingley to Henry Ford Jackson Hospital for a mental health evaluation; doctors did not find that involuntary hospitalization was necessary but confirmed a urinary tract infection and gave her antibiotics. Vista Grande declared she could not return unless the family agreed to sedating medication, according to hospital records; in a court filing, Vista Grande said Tingley had become a “danger to herself and others.” Administrators at Vista Grande began calling 911 after altercations, according to ambulance and police dispatch records.

The family authorized Vista Grande to administer Ativan (lorazepam) on an as-needed basis; Ativan is a benzodiazepine the FDA has approved for anxiety, whose label says it can cause dizziness, unsteadiness, and weakness, and is supposed to be used “with caution” in patients with breathing problems — Tingley had sleep apnea — and warns of “paradoxical” reactions such as agitation and rage. After a week, facility workers gave “mixed reports” about whether Ativan was calming Tingley, according to her medical records.

The family then authorized Zyprexa (olanzapine) as a replacement, at 2.5 milligrams per day — half the Eli Lilly starter dose — citing the FDA-required black box warning that the drug is not approved for treatment of patients with dementia-related psychosis and places them at greater risk of death; the sons cited concerns about cardiac side effects given Tingley’s atrial fibrillation. A psychiatrist consulting with the hospital endorsed doubling the Zyprexa to the starter dose recommended by Eli Lilly, and the Tingleys consented, according to medical records; for five days there were no incidents at Vista Grande. The family later alleged in court filings that Tingley was being excessively sedated and instructed that the Zyprexa be cut back to its initial level; the sons said they were especially disturbed to learn she was being given both Ativan and Zyprexa after they had approved Zyprexa as a replacement drug.

After the family resisted further medication increases, Vista Grande sent Tingley to the emergency room four times before issuing a 30-day eviction notice on Jan. 2, 2025; the notice stated: “We have determined we are unable to meet the level of care and expectations required for your mother’s well-being.” The facility sent Tingley to the hospital four more times while the family arranged a new placement; on both New Year’s Eve and New Year’s Day Vista Grande sent her to the emergency room.

On the last trip, Jennifer Wheeler, then-director of Vista Grande’s memory care unit, told ambulance workers that Marjorie would not be accepted back, according to EMS notes: “She is a danger to other residents and a danger to my staff.” An earlier dispatch entry records a flustered administrator telling an ambulance crew: “I want her out of here.”

Tingley stayed in the hospital until she was moved to another memory care facility in Jackson; she died on Jan. 26, 2025, less than two weeks later. The cause was plaque buildup in her brain, a hallmark of Alzheimer’s, a degenerative brain disease and the most common type of dementia. The sons have asserted in court filings that the frequent trips back and forth to the hospital hastened their mother’s demise.

Bedside records versus facility narrative

Hospital and ambulance records described Tingley as cooperative and polite throughout her emergency-room visits, according to the sons. A physician treating Tingley in the emergency room wrote in her record: “Her behavior on what I am witnessing is completely contrary to what they are indicating.” An ER worker described Tingley as “Just the sweetest patient and very loving.” A nurse said Tingley allowed her to braid her hair and blew her kisses when she left.

Vista Grande, in a legal filing, called the drugs recommended to the Tingleys “routine medication” and said it sent their mother to the hospital “because of her family’s refusal to allow Ms. Tingley to be treated on site.” Vista Grande attributed her calm at the emergency room to medication and to the “familial love and attention” her sons gave her, and stated: “The next time Ms. Tingley decompensated, the cycle predictably resumed.” Vista Grande and its director at the time have denied the allegations. Attorneys for Vista Grande and its former director did not respond to requests for comment.

Mark Tingley characterized the dynamic at the time: “It’s like they’re holding her ransom unless I say she can have that pill.” David Tingley said about Vista Grande: “They just wanted to have her drugged up. It’s a lot easier to take care of someone who’s just out of it.”

Lauren Gerlach, a geriatric psychiatrist and an associate professor at the University of Michigan Medical School, said that there is evidence that aggressive behaviors are better addressed by non-medication interventions, like looking for underlying medical issues or heading off situations that typically upset the person, but added: “for some patients, these behaviors are so severe that medications will be required.”

Prescribing pathway and unnamed parties

The specific medications were prescribed either by hospital doctors or a nurse practitioner working for a medical group that serviced residents of Vista Grande and other long-term care facilities, according to medical records. The lawsuit did not name the nurse practitioner, the medical group, or the hospital as defendants. Henry Ford Health declined to comment. According to David Tingley, Vista Grande had encouraged the family to replace their mother’s longtime physician with that medical group.

The sons’ lawsuit against Vista Grande and its director at the time accused the facility of negligence, causing emotional distress, and wrongful eviction; the suit also asserted Vista Grande initiated the ER trips in retaliation for the family’s disagreements about Tingley’s care.

Eli Lilly’s 2009 plea and a half-century of documented concerns

Eli Lilly, Zyprexa’s manufacturer, pleaded guilty in 2009 to allegations that it improperly promoted the drug’s use for dementia with long-term care providers and primary care physicians, agreeing to pay a criminal fine and civil settlement totaling $1.4 billion. The plea concerned promotion directed at long-term care providers — the same venue category where the federal antipsychotic-reduction campaign has had its most limited reach. Zyprexa has a long history of being prescribed off-label for dementia-related psychosis. The long-term care industry’s reliance on tranquilizing medications has been a concern of Congress for half a century; a 1975 Senate report stated that “an ugly pattern of prescription drug misuse, with harsh consequences to patients, exists in many nursing homes of the United States.”

Litigation, corporate succession, and present status

A Michigan Circuit Court judge has dismissed the negligence claim against Vista Grande on legal grounds. A trial is scheduled for early next year on the remainder of the lawsuit if mediation fails. During the litigation, Vista Grande — which was a nonprofit — became a wholly-owned subsidiary of Otterbein SeniorLife and was renamed Otterbein Jackson SeniorLife Community; Otterbein is not named in the lawsuit. Representatives of Otterbein did not respond to requests for comment.

What happens next

Under a baseline trajectory, federal enforcement of the CMS campaign continues to reduce nursing home prescribing while assisted living overprescription persists; absent federal action to extend CMS authority, the structural gap appears likely to widen as the population needing dementia care grows.

Under a regulatory-tightening trajectory, the inspector general’s findings and JAMA-published research catalyze either congressional action to extend federal oversight to assisted living facilities or a CMS rule that conditions Medicare or Medicaid participation on antipsychotic stewardship across care settings; state legislatures may also move to require non-pharmacological intervention protocols before antipsychotic prescription.

Under a discontinuity scenario, a major whistleblower case or class-action settlement analogous to Eli Lilly’s 2009 resolution produces a wave of enforcement actions against manufacturers and prescribers; the 2009 Lilly case demonstrates that such events have occurred in this domain and have produced documented changes in marketing — though not, the cited 2017 research suggests, in prescribing.

Under a reversal trajectory, expanded training programs, dementia-care certification standards, or alternative payment models that reimburse caregiver time rather than per-medication encounters displace antipsychotics as the default response to behavioral incidents; the underlying reporting documents that Gerlach and other geriatric psychiatrists consider this approach evidence-based but under-resourced.

What the reporting does not establish

Specific study citations — the JAMA study, 2023 JAMDA study, 2017 antipsychotic-prescribing trends research, 1975 Senate report — are referenced in the underlying reporting but the underlying reporting does not provide authors, titles, DOIs, or committee names. Michigan’s adult foster care and assisted living inspection, complaint, and discharge regulatory framework is not enumerated in the underlying reporting. The $9,150 monthly figure is attributed to “her lease shows” but the lease itself is not in the underlying reporting.

Analytical techniques used in this piece

This analysis applies the methods below. Each links to a short, plain-English explainer you can read and reuse.

Domain Induction: Builds a working mental model of a domain from the ground up.
Quick Orientation: A fast lay-of-the-land read of an unfamiliar domain.
Wicked Futures: Explores a long-horizon, deeply entangled future with no clean resolution.
Tit-for-Tat: Reciprocity as strategy: match the other side’s last move — reward cooperation, punish defection.
Tragedy of the Commons: A shared resource is depleted because each user’s incentive is to take more.